June 1, 2020
Bristol Myers Squibb Announces Commercial Launch and Availability of ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis
- /
- /
Stay Healthy, Stay Home and Wash Your Hands Click HERE to Subscribe for the MS Beacon Newsletter ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Press Release…
